Kolexia
Josset Laurence
Pharmacien
Hôpital La Croix-Rousse
Lyon, France
103 Activités
109 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Grippe humaine Infections de l'appareil respiratoire Infections à entérovirus Maladies virales Co-infection Infections à Orthomyxoviridae Syndrome respiratoire aigu sévère Hépatite D

Industries

Sanofi
5 collaboration(s)
Dernière en 2019
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

COVID-IVAC: Characterization of the Viral Genome and Humoral Immune Response in COVID-19 Vaccinated Patients With SARS-CoV-2 Infection
Essai Clinique (Hospices Civils de Lyon)   14 mars 2024
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial.
The Journal of infection   16 février 2024
Virological and clinical features of acute respiratory failure associated with COVID-19 in pregnancy: a case-control study.
Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine   18 octobre 2023
Determinants of protection against SARS-CoV-2 Omicron BA.1 and Delta infections in fully vaccinated outpatients.
Journal of medical virology   31 juillet 2023
Novel UL23 and UL30 substitutions in HSV1 and HSV2 viruses related to polymorphism or drug resistance.
Antiviral research   14 juillet 2023
Emergence, spread and characterisation of the SARS-CoV-2 variant B.1.640 circulating in France, October 2021 to February 2022.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin   05 juin 2023
Long-term humoral response following Delta and Omicron BA.1 co-infection.
NPJ vaccines   20 avril 2023
A third vaccine dose equalises the levels of effectiveness and immunogenicity of heterologous or homologous COVID-19 vaccine regimens, Lyon, France, December 2021 to March 2022.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin   18 avril 2023
Méningo-radiculite à Borrelia miyamotoi sous anti-CD20, identifiée par analyse méta-transcriptomique du LCR
Journées de Neurologie de Langue Française 2023   01 avril 2023
Improved hepatitis delta virus genome characterization by single molecule full-length genome sequencing combined with VIRiONT pipeline.
Journal of medical virology   30 mars 2023